Compare ADPT & XRAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADPT | XRAY |
|---|---|---|
| Founded | 2009 | 1899 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.6B |
| IPO Year | 2019 | 1987 |
| Metric | ADPT | XRAY |
|---|---|---|
| Price | $18.46 | $12.70 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 12 |
| Target Price | ★ $16.60 | $14.50 |
| AVG Volume (30 Days) | 1.9M | ★ 4.0M |
| Earning Date | 02-05-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 5.03% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $252,754,000.00 | ★ $3,624,000,000.00 |
| Revenue This Year | $50.86 | N/A |
| Revenue Next Year | $0.53 | $0.86 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 42.57 | N/A |
| 52 Week Low | $6.26 | $9.85 |
| 52 Week High | $20.76 | $20.60 |
| Indicator | ADPT | XRAY |
|---|---|---|
| Relative Strength Index (RSI) | 59.49 | 59.24 |
| Support Level | $16.55 | $11.95 |
| Resistance Level | $19.16 | $12.60 |
| Average True Range (ATR) | 1.00 | 0.53 |
| MACD | 0.18 | 0.06 |
| Stochastic Oscillator | 82.08 | 81.66 |
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is either sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).